Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2021 13:00 ET | Source: Sorrento Therapeutics, Inc.

Sorrento and Researchers at Karolinska Institutet Have Signed a Research Collaboration Agreement on iPSC-Derived Dimeric Antigen Receptor-Modified Natural Killer (DAR-NK) Cells With The Vision to Bring “Off-The-Shelf" NK Cell-Based Cancer Treatments Rapidly to Patients

SAN DIEGO and STOCKHOLM, Sweden, June 04, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that the Company has entered into an additional...
September 18, 2019 11:10 ET | Source: AroCell AB

Tymidinkinas 1 kan användas för tidigt terapisvar vid behandling av bröstcancer

Patienter behandlade med Epirubicin och Docetaxel före operationen följdes med deras tymidinkinas (TK1) nivåer i blodet för att direkt observera behandlingssvaret. Resultaten visar att en TK1-baserat...
September 18, 2019 11:10 ET | Source: AroCell AB

Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment

Patients treated with Epirubicin and Docetaxel before surgery were followed by their thymidine kinase (TK1) levels in blood to directly observe treatment response. The results show that a TK1-based...
September 05, 2014 09:10 ET | Source: North Shore Long Island Jewish Health System

Feinstein Institute Presents Cerami Award to Karolinska Institutet Researcher

MANHASSET, N.Y., Sept. 5, 2014 (GLOBE NEWSWIRE) -- The Feinstein Institute for Medical Research and Molecular Medicine announced today that it will confer the second Anthony Cerami Award in...